Nausea and vomiting epidemiology and demographics: Difference between revisions
| Line 5: | Line 5: | ||
In population studies, more than 50% of adults reported at least one episode of nausea, and more than 30% of adults reported one episode of vomiting within the preceding 12 months, with women reporting more episodes of nausea than men | In population studies, more than 50% of adults reported at least one episode of nausea, and more than 30% of adults reported one episode of vomiting within the preceding 12 months, with women reporting more episodes of nausea than men | ||
Incidence | ===Incidence=== | ||
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | ||
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
Prevalence | ===Prevalence=== | ||
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | ||
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
| Line 15: | Line 15: | ||
In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | ||
The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | ||
Age | ===Age=== | ||
Patients of all age groups may develop [disease name]. | Patients of all age groups may develop [disease name]. | ||
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | ||
| Line 21: | Line 21: | ||
[Chronic disease name] is usually first diagnosed among [age group]. | [Chronic disease name] is usually first diagnosed among [age group]. | ||
[Acute disease name] commonly affects [age group]. | [Acute disease name] commonly affects [age group]. | ||
Race | ===Race=== | ||
There is no racial predilection to [disease name]. | There is no racial predilection to [disease name]. | ||
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
Gender | ===Gender=== | ||
women report more episodes of nausea than men. | women report more episodes of nausea than men. | ||
Developed Countries | ===Developed Countries=== | ||
Developing Countries | ===Developing Countries=== | ||
==References== | ==References== | ||
Revision as of 04:10, 9 October 2020
|
Nausea and vomiting Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nausea and vomiting epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nausea and vomiting epidemiology and demographics |
|
Nausea and vomiting epidemiology and demographics in the news |
|
Risk calculators and risk factors for Nausea and vomiting epidemiology and demographics |
Overview
Epidemiology and demographics
In population studies, more than 50% of adults reported at least one episode of nausea, and more than 30% of adults reported one episode of vomiting within the preceding 12 months, with women reporting more episodes of nausea than men
Incidence
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. The prevalence of [disease/malignancy] is estimated to be [number] cases annually. Case-fatality rate/Mortality rate In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
Patients of all age groups may develop [disease name]. The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. [Disease name] commonly affects individuals younger than/older than [number of years] years of age. [Chronic disease name] is usually first diagnosed among [age group]. [Acute disease name] commonly affects [age group].
Race
There is no racial predilection to [disease name]. [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
women report more episodes of nausea than men.